Abdullah Alsuliman

1.8k total citations
15 papers, 588 citations indexed

About

Abdullah Alsuliman is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Abdullah Alsuliman has authored 15 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Hematology and 5 papers in Oncology. Recurrent topics in Abdullah Alsuliman's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (3 papers). Abdullah Alsuliman is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (3 papers). Abdullah Alsuliman collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Abdullah Alsuliman's co-authors include Taher Al‐Tweigeri, Dilek Çolak, Asma Tulbah, Hazem Ghebeh, Olfat Al‐Harazi, Monther Al‐Alwan, Elizabeth J. Shpall, Stanley H. Appel, David R. Beers and Weihua Zhao and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Abdullah Alsuliman

15 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdullah Alsuliman United States 9 236 225 134 107 105 15 588
Rachel Popow United States 5 293 1.2× 261 1.2× 42 0.3× 34 0.3× 97 0.9× 6 611
Ilan Kolkowitz United States 6 308 1.3× 178 0.8× 96 0.7× 77 0.7× 164 1.6× 8 637
Czrina Cortez United States 7 451 1.9× 398 1.8× 217 1.6× 63 0.6× 265 2.5× 9 891
Helen Travers United Kingdom 11 145 0.6× 104 0.5× 254 1.9× 18 0.2× 448 4.3× 16 905
Irune Ruiz Spain 13 42 0.2× 164 0.7× 106 0.8× 66 0.6× 348 3.3× 25 672
Emily C. Brantley United States 7 182 0.8× 268 1.2× 14 0.1× 41 0.4× 263 2.5× 8 593
Marc Lamarine Switzerland 8 166 0.7× 61 0.3× 95 0.7× 32 0.3× 166 1.6× 10 467
Setareh Shamsili Netherlands 9 90 0.4× 215 1.0× 668 5.0× 28 0.3× 364 3.5× 14 1.1k
Tatiana Kaptzan Israel 10 96 0.4× 46 0.2× 47 0.4× 56 0.5× 131 1.2× 13 327
Peter Mercado United States 7 246 1.0× 227 1.0× 21 0.2× 25 0.2× 290 2.8× 8 669

Countries citing papers authored by Abdullah Alsuliman

Since Specialization
Citations

This map shows the geographic impact of Abdullah Alsuliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Alsuliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Alsuliman more than expected).

Fields of papers citing papers by Abdullah Alsuliman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Alsuliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Alsuliman. The network helps show where Abdullah Alsuliman may publish in the future.

Co-authorship network of co-authors of Abdullah Alsuliman

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Alsuliman. A scholar is included among the top collaborators of Abdullah Alsuliman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Alsuliman. Abdullah Alsuliman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Janssen, Erin, Anas M. Alazami, Abdullah Alsuliman, et al.. (2022). A homozygous truncating mutation of FGL2 is associated with immune dysregulation. Journal of Allergy and Clinical Immunology. 151(2). 572–578.e1. 2 indexed citations
2.
Weathers, Shiao‐Pei, Marta Penas‐Prado, Pinaki P. Banerjee, et al.. (2020). A phase I/II clinical trial of autologous CMV-specific T cells in glioblastoma (GBM) patients to reveal a lack of immune effector function.. Journal of Clinical Oncology. 38(15_suppl). 2515–2515. 4 indexed citations
3.
Khoder, Ahmad, Abdullah Alsuliman, Rafet Başar, et al.. (2018). Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease. Frontiers in Immunology. 8. 1937–1937. 28 indexed citations
4.
Beers, David R., Weihua Zhao, Jinghong Wang, et al.. (2017). ALS patients’ regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2(5). e89530–e89530. 158 indexed citations
5.
Alsuliman, Abdullah, Muharrem Müftüoğlu, Ahmad Khoder, et al.. (2016). A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML. Blood. 129(6). 740–758. 23 indexed citations
6.
Alsuliman, Abdullah, Stanley H. Appel, David R. Beers, et al.. (2016). A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy. 18(10). 1312–1324. 40 indexed citations
7.
Alsuliman, Abdullah, Dilek Çolak, Olfat Al‐Harazi, et al.. (2015). Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells. Molecular Cancer. 14(1). 149–149. 212 indexed citations
8.
Shaim, Hila, Zeev Estrov, Takuya Sekine, et al.. (2015). The CXCR4/STAT3/IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia (CLL) and Can be Modulated By Lenalidomide. Blood. 126(23). 1709–1709. 3 indexed citations
9.
Kondo, Kayo, Jan A. Burger, M Keating, et al.. (2015). Ibrutinib Can Modulate the T Cell Response in Chronic Lymphocytic Leukemia By Reducing PD1/PDL1 Interactions. Blood. 126(23). 1737–1737. 5 indexed citations
10.
Ghebeh, Hazem, Dilek Çolak, Asma Tulbah, & Abdullah Alsuliman. (2015). Towards targeting PD-1/PD-L1 axis in breast cancer, pre-clinical data. Journal for ImmunoTherapy of Cancer. 3(S1). 1 indexed citations
11.
12.
Khoder, Ahmad, Abdullah Alsuliman, Takuya Sekine, et al.. (2013). Evidence for Expansion of CD21− B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD. Biology of Blood and Marrow Transplantation. 19(2). S139–S140. 1 indexed citations
13.
Marín, David, Ian H Gabriel, Sohail Ahmad, et al.. (2011). KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib. Leukemia. 26(2). 296–302. 41 indexed citations
14.
Gabriel, Ian H, Ruhena Sergeant, Richard Szydlo, et al.. (2010). Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma. Blood. 116(12). 2033–2039. 39 indexed citations
15.
Gaafar, Ameera, et al.. (2009). HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.. PubMed. 15. 1876–80. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Popow Breakdown of academic impact, for papers by Ilan Kolkowitz Breakdown of academic impact, for papers by Czrina Cortez Breakdown of academic impact, for papers by Helen Travers Breakdown of academic impact, for papers by Irune Ruiz Breakdown of academic impact, for papers by Emily C. Brantley Breakdown of academic impact, for papers by Marc Lamarine Breakdown of academic impact, for papers by Setareh Shamsili Breakdown of academic impact, for papers by Tatiana Kaptzan Breakdown of academic impact, for papers by Peter Mercado
Rankless by CCL
2026